Ningbo Menovo Pharmaceutical Co., Ltd. (SHA:603538)
China · Delayed Price · Currency is CNY 65.30
+5.18 (8.62%)
Apr 29, 2026, 3:00 PM CST
SHA:603538 Revenue
Ningbo Menovo Pharmaceutical had revenue of 337.65M CNY in the quarter ending March 31, 2026, with 22.12% growth. This brings the company's revenue in the last twelve months to 1.56B, up 12.82% year-over-year. In the year 2025, Ningbo Menovo Pharmaceutical had annual revenue of 1.50B with 9.49% growth.
Revenue (ttm)
1.56B
Revenue Growth
+12.82%
P/S Ratio
9.20
Revenue / Employee
632.80K
Employees
2,404
Market Cap
14.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.50B | 130.27M | 9.49% |
| Dec 31, 2024 | 1.37B | 156.36M | 12.85% |
| Dec 31, 2023 | 1.22B | -240.48M | -16.51% |
| Dec 31, 2022 | 1.46B | 198.83M | 15.80% |
| Dec 31, 2021 | 1.26B | 64.77M | 5.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Hisun Pharmaceutical | 10.31B |
| Shanghai Shyndec Pharmaceutical | 9.36B |
| Zhejiang CONBA Pharmaceutical | 6.69B |
| Guobang Pharma | 6.09B |
| Zhejiang Jiuzhou Pharmaceutical | 5.22B |
| Zhejiang Jingxin Pharmaceutical | 4.00B |
| Henan Lingrui Pharmaceutical | 3.78B |
| Porton Pharma Solutions | 3.50B |